Testing a new drug for metastatic prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a new drug, HRS-5041, for men whose prostate cancer has spread and stopped responding to hormone therapy. The goal is to see if the drug is safe and can help control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your cancer has spread to other parts of the body and is no longer controlled by hormone therapy.
- You have good bone marrow, liver, and organ function.
- You haven't had other cancer treatments like chemotherapy, radiation, or surgery in the past 4 weeks.
- You can swallow pills and don't have ongoing diarrhea or bowel problems.
- You don't have uncontrolled high blood pressure (above 150/100) or a serious heart condition in the last 6 months.
- You don't have a history of other cancer in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing an investigational drug, HRS-7525, for men with advanced prostate cancer that has spread to other parts of the body. The goal is to see if the drug is safe and effective.
This Phase 1 trial tests HRS-5041 in people with metastatic castration-resistant prostate cancer (prostate cancer that keeps growing despite lower testosterone). It aims to see if the drug can be given safely and whether it may help control the cancer after prior standard treatments.
This trial tests two new drugs, HRS-2189 and HRS-5041, for men with prostate cancer that has spread to other parts of the body and is getting worse. The goal is to see if this combination can help slow down the cancer.
This trial tests a combination of two experimental drugs, HS-20093 and HRS-5041, for men with advanced prostate cancer that has stopped responding to standard hormone therapy. The goal is to see if this new treatment can help control the cancer when other treatments have stopped working.
This trial tests a new tablet called HRS-5041 combined with other anti-cancer treatments for men with advanced prostate cancer that has not responded to previous therapies. It aims to see how well the combination works and if it is safe.
This trial tests a new drug, HRS-4357, against standard treatments for men with a specific type of advanced prostate cancer that has spread and no longer responds to hormone therapy. It aims to see if the new drug works better.
Hear when a new Metastatic Castration-resistant Prostate Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.